[1] F. Bray, J. Ferlay, I. Soerjomataram, R.L. Siegel, L.A. Torre, A. Jemal, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin 68 (2018) 394-424.
[2] G.P. Gupta, J. Massagué, Cancer metastasis: building a framework, Cell 127 (2006) 679-695.
[3] R. Wagener, B. Kobbe, M. Paulsson, Primary structure of matrilin-3, a new member of a family of extracellular matrix proteins related to cartilage matrix protein (matrilin-1) and von Willebrand factor, FEBS Lett. 413 (1997) 129-134.
[4] Y. Zhang, Z.K. Wang, J.M. Luo, K. Kanbe, Q. Chen, Multiple functions of the von Willebrand Factor A domain in matrilins: secretion, assembly, and proteolysis, J Orthop Surg Res 3 (2008) 21.
[5] A.R. Klatt, D.P. Nitsche, B. Kobbe, M. Mörgelin, M. Paulsson, R. Wagener, Molecular structure and tissue distribution of matrilin-3, a filament-forming extracellular matrix protein expressed during skeletal development, J. Biol. Chem. 275 (2000) 3999-4006.
[6] K.L. Chapman, G.R. Mortier, K. Chapman, J. Loughlin, M.E. Grant, M.D. Briggs, Mutations in the region encoding the von Willebrand factor A domain of matrilin-3 are associated with multiple epiphyseal dysplasia, Nat. Genet. 28 (2001) 393-396.
[7] A. Mabuchi, N. Haga, K. Maeda, E. Nakashima, N. Manabe, H. Hiraoka, et al., Novel and recurrent mutations clustered in the von Willebrand factor A domain of MATN3 in multiple epiphyseal dysplasia, Hum. Mutat. 24 (2004) 439-440.
[8] J. Kruppa, K. Jung, Automated multigroup outlier identification in molecular high-throughput data using bagplots and gemplots, BMC Bioinformatics 18 (2017) 232.
[9] A. Subramanian, P. Tamayo, V.K. Mootha, S. Mukherjee, B.L. Ebert, M.A. Gillette, et al., Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 15545-15550.
[10] A.R. Klatt, A.K. Becker, C.D. Neacsu, M. Paulsson, R. Wagener, The matrilins: modulators of extracellular matrix assembly, Int. J. Biochem. Cell Biol. 43 (2011) 320-330.
[11] R. Wagener, H.W. Ehlen, Y.P. Ko, B. Kobbe, H.H. Mann, G. Sengle, et al., The matrilins--adaptor proteins in the extracellular matrix, FEBS Lett. 579 (2005) 3323-3329.
[12] A.R. Klatt, G. Klinger, B. Paul-Klausch, G. Kühn, J.H. Renno, R. Wagener, et al., Matrilin-3 activates the expression of osteoarthritis-associated genes in primary human chondrocytes, FEBS Lett. 583 (2009) 3611-3617.
[13] C.T. Jayasuriya, F.H. Zhou, M. Pei, Z. Wang, N.J. Lemme, P. Haines, et al., Matrilin-3 chondrodysplasia mutations cause attenuated chondrogenesis, premature hypertrophy and aberrant response to TGF-β in chondroprogenitor cells, Int J Mol Sci 15 (2014) 14555-14573.
[14] M.S. Muttigi, I. Han, H.K. Park, H. Park, S.H. Lee, Matrilin-3 Role in Cartilage Development and Osteoarthritis, Int J Mol Sci 17 (2016)
[15] Y.Y. Zhou, Y.T. Kang, C. Chen, F.F. Xu, H.N. Wang, R. Jin, Combination of TNM staging and pathway based risk score models in patients with gastric cancer, J. Cell. Biochem. 119 (2018) 3608-3617.
[16] P.L. Wu, Y.F. He, H.H. Yao, B. Hu, Martrilin-3 (MATN3) Overexpression in Gastric Adenocarcinoma and its Prognostic Significance, Med. Sci. Monit. 24 (2018) 348-355.
[17] Z. Aburjania, S. Jang, J. Whitt, R. Jaskula-Stzul, H. Chen, J.B. Rose, The Role of Notch3 in Cancer, Oncologist 23 (2018) 900-911.
[18] T.S. Yeh, C.W. Wu, K.W. Hsu, W.J. Liao, M.C. Yang, A.F. Li, et al., The activated Notch1 signal pathway is associated with gastric cancer progression through cyclooxygenase-2, Cancer Res. 69 (2009) 5039-5048.
[19] Y.C. Tseng, Y.H. Tsai, M.J. Tseng, K.W. Hsu, M.C. Yang, K.H. Huang, et al., Notch2-induced COX-2 expression enhancing gastric cancer progression, Mol. Carcinog. 51 (2012) 939-951.
[20] W. Zhou, X.Q. Fu, L.L. Zhang, J. Zhang, X. Huang, X.H. Lu, et al., The AKT1/NF-kappaB/Notch1/PTEN axis has an important role in chemoresistance of gastric cancer cells, Cell Death Dis 4 (2013) e847.
[21] L.Y. Guo, Y.M. Li, L. Qiao, T. Liu, Du YY, J.Q. Zhang, et al., Notch2 regulates matrix metallopeptidase 9 via PI3K/AKT signaling in human gastric carcinoma cell MKN-45, World J. Gastroenterol. 18 (2012) 7262-7270.
[22] H. Kang, H.J. An, J.Y. Song, T.H. Kim, J.H. Heo, D.H. Ahn, et al., Notch3 and Jagged2 contribute to gastric cancer development and to glandular differentiation associated with MUC2 and MUC5AC expression, Histopathology 61 (2012) 576-586.
[23] C. Qian, F. Liu, B. Ye, X. Zhang, Y. Liang, J. Yao, Notch4 promotes gastric cancer growth through activation of Wnt1/β-catenin signaling, Mol. Cell. Biochem. 401 (2015) 165-174.
[24] E.S. Hibdon, N. Razumilava, T.M. Keeley, G. Wong, S. Solanki, Y.M. Shah, et al., Notch and mTOR Signaling Pathways Promote Human Gastric Cancer Cell Proliferation, Neoplasia 21 (2019) 702-712.
[25] Y. Guo, P. Xiao, S. Lei, F. Deng, G.G. Xiao, Y. Liu, et al., How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes, Acta Biochim. Biophys. Sin. (Shanghai) 40 (2008) 426-436.